In patients with reperfusion therapy due to ischemic heart disease and after myocardial infarction, PGRN was demonstrated to have a cardioprotective role due to its anti-inflammatory, anti-atherogenic, and antioxidant effect associated with increased nitrogen monoxide synthesis [26,44]. This evidence concerns the gene GRN and myocardial infarction.